<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>β-Arrestins (Arrb) participate in the regulation of multiple signaling pathways, including Wnt/β-catenin, the major actor in human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> initiation </plain></SENT>
<SENT sid="1" pm="."><plain>To better understand the roles of Arrb in intestinal <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, a reverse genetic approach (Arrb(-/-)) and in vivo siRNA treatment were used in Apc(Δ14/+) mice </plain></SENT>
<SENT sid="2" pm="."><plain>Mice with Arrb2 <z:mpath ids='MPATH_63'>depletion</z:mpath> (knockout and siRNA) developed only 33% of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> detected in their Arrb2-WT littermates, whereas Arrb1 <z:mpath ids='MPATH_63'>depletion</z:mpath> remained without significant effect </plain></SENT>
<SENT sid="3" pm="."><plain>These remaining <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> grow normally and are essentially Arrb2-independent </plain></SENT>
<SENT sid="4" pm="."><plain>Unsupervised hierarchical clustering analysis showed that they clustered with 25% of Apc(Δ14/+);Arrb2(+/+) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Genes overexpressed in this subset reflect a high interaction with the immune system, whereas those overexpressed in Arrb2-dependent <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> are predominantly involved in Wnt signaling, cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e>, migration, and extracellular matrix remodeling </plain></SENT>
<SENT sid="6" pm="."><plain>The involvement of Arrb2 in <z:e sem="disease" ids="C0021841" disease_type="Neoplastic Process" abbrv="">intestinal tumor</z:e> development via the regulation of the Wnt pathway is supported by ex vivo and in vitro experiments using either <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> from Apc(Δ14/+) mice or murine Apc(Min/+) cells </plain></SENT>
<SENT sid="7" pm="."><plain>Indeed, Arrb2 siRNAs decreased the expression of Wnt target genes in cells isolated from 12 of 18 tumors from Apc(Δ14/+) mice </plain></SENT>
<SENT sid="8" pm="."><plain>In Apc(Min/+) cells, Arrb2 siRNAs completely reversed the increased Wnt activity and colony formation in soft agar induced by Apc siRNA treatment, whereas they did not affect these parameters in basal conditions or in cells expressing constitutively active β-catenin </plain></SENT>
<SENT sid="9" pm="."><plain>We demonstrate that Arrb2 is essential for the initiation and growth of <z:e sem="disease" ids="C0021841" disease_type="Neoplastic Process" abbrv="">intestinal tumors</z:e> displaying elevated Wnt pathway activity and identify a previously unsuspected molecular <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> among <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> induced by truncating Apc mutations </plain></SENT>
</text></document>